Synthesis and in vitro binding of N,N-Dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites
dc.contributor.author | Homes, TP | en_AU |
dc.contributor.author | Mattner, F | en_AU |
dc.contributor.author | Keller, PA | en_AU |
dc.contributor.author | Katsifis, A | en_AU |
dc.date.accessioned | 2014-10-09T23:24:30Z | en_AU |
dc.date.available | 2014-10-09T23:24:30Z | en_AU |
dc.date.issued | 2006-06-01 | en_AU |
dc.date.statistics | 2014-10-10 | en_AU |
dc.description.abstract | A series of NN-dialkyl-2-phenylindol-3-glyoxylamides bearing the halogens iodine and bromine were synthesised and their binding affinity for the peripheral benzodiazepine binding sites (PBBS) in rat kidney mitochondrial membranes was evaluated Using [H-3]PK11195. Central benzodiazepine receptor (CBR) affinities were also evaluated in rat cortices using [H-3]flumazenil to determine their selectivity for PBBS over CBR. The tested compounds had PBBS binding affinities (IC50) ranging from 7.86 to 618 nM, with all compounds showing high selectivity over the CBR (CBR IC50 > 5000 nM). Among the 12 compounds tested, those with a diethylamide group were the most potent. The highest affinity iodinated PBBS ligand, N,N-diethyl-[5-chloro-2-(4-iodophenyl)indol-3-yl]glyoxylamide (4c), was radiolabelled with iodine-123. This high affinity and selective radioligand may be useful for imaging neurodegencration, inflammation and tumours using single photon emission computed tomography. © 2006, Elsevier Ltd. | en_AU |
dc.identifier.citation | Homes, T. P., Mattner, F., Keller, P. A., & Katsifis, A. (2006). Synthesis and in vitro binding of N,N-Dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites. Bioorganic & Medicinal Chemistry, 14(11), 3938-3946. doi:10.1016/j.bmc.2006.01.039 | en_AU |
dc.identifier.govdoc | 4522 | en_AU |
dc.identifier.issn | 0968-0896 | en_AU |
dc.identifier.issue | 11 | en_AU |
dc.identifier.journaltitle | Bioorganic & Medicinal Chemistry | en_AU |
dc.identifier.pagination | 3938-3946 | en_AU |
dc.identifier.uri | http://dx.doi.org/10.1016/j.bmc.2006.01.039 | en_AU |
dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/5907 | en_AU |
dc.identifier.volume | 14 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | Pergamon-Elsevier Science Ltd | en_AU |
dc.subject | Central nervous system | en_AU |
dc.subject | Nervous system | en_AU |
dc.subject | Iron | en_AU |
dc.subject | Iodination | en_AU |
dc.subject | Brain | en_AU |
dc.subject | Inflammation | en_AU |
dc.title | Synthesis and in vitro binding of N,N-Dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: